Joseph Ciaffoni - Net Worth and Insider Trading
Joseph Ciaffoni Net Worth
The estimated net worth of Joseph Ciaffoni is at least $8 Million dollars as of 2024-12-28. Joseph Ciaffoni is the President and CEO of Collegium Pharmaceutical Inc and owns about 275,000 shares of Collegium Pharmaceutical Inc (COLL) stock worth over $8 Million. Details can be seen in Joseph Ciaffoni's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph Ciaffoni has not made any transactions after 2023-12-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joseph Ciaffoni
Joseph Ciaffoni Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph Ciaffoni owns 2 companies in total, including Collegium Pharmaceutical Inc (COLL) , and Endo International PLC (ENDPQ) .
Click here to see the complete history of Joseph Ciaffoni’s form 4 insider trades.
Insider Ownership Summary of Joseph Ciaffoni
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| COLL | Collegium Pharmaceutical Inc | 2023-12-21 | director & President and CEO |
| ENDPQ | Endo International PLC | 2016-08-15 | President & U.S. Branded Pharma |
Joseph Ciaffoni Latest Holdings Summary
Joseph Ciaffoni currently owns a total of 1 stock. Joseph Ciaffoni owns 275,000 shares of Collegium Pharmaceutical Inc (COLL) as of December 21, 2023, with a value of $8 Million.
Latest Holdings of Joseph Ciaffoni
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| COLL | Collegium Pharmaceutical Inc | 2023-12-21 | 275,000 | 29.11 | 8,005,250 |
Holding Weightings of Joseph Ciaffoni
Joseph Ciaffoni Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph Ciaffoni has made a total of 13 transactions in Collegium Pharmaceutical Inc (COLL) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Collegium Pharmaceutical Inc is the sale of 4,357 shares on December 21, 2023, which brought Joseph Ciaffoni around $132,366.
Insider Trading History of Joseph Ciaffoni
- 1
Joseph Ciaffoni Trading Performance
Joseph Ciaffoni Ownership Network
Joseph Ciaffoni Owned Company Details
What does Collegium Pharmaceutical Inc do?
Who are the key executives at Collegium Pharmaceutical Inc?
Joseph Ciaffoni is the director & President and CEO of Collegium Pharmaceutical Inc. Other key executives at Collegium Pharmaceutical Inc include EVP and Chief Medical Officer Thomas B Smith , EVP and General Counsel Shirley R. Kuhlmann , and EVP & Chief Financial Officer Tupper Colleen .
Collegium Pharmaceutical Inc (COLL) Insider Trades Summary
Over the past 18 months, Joseph Ciaffoni made 2 insider transaction in Collegium Pharmaceutical Inc (COLL) with a net sale of 73,125. Other recent insider transactions involving Collegium Pharmaceutical Inc (COLL) include a net sale of 141,576 shares made by Scott Dreyer , a net sale of 70,825 shares made by Shirley R. Kuhlmann , and a net sale of 28,985 shares made by Garen G Bohlin .
In summary, during the past 3 months, insiders sold 0 shares of Collegium Pharmaceutical Inc (COLL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 343,814 shares of Collegium Pharmaceutical Inc (COLL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 343,814 shares.
Collegium Pharmaceutical Inc (COLL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Collegium Pharmaceutical Inc Insider Transactions
Joseph Ciaffoni Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph Ciaffoni. You might contact Joseph Ciaffoni via mailing address: 100 Technology Center Drive, Stoughton Ma 02072.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
